| Statins and cancer risk: a meta-analysis KM Dale, CI Coleman, NN Henyan, J Kluger, CM White Jama 295 (1), 74-80, 2006 | 760 | 2006 |
| Effect of statins on skeletal muscle function BA Parker, JA Capizzi, AS Grimaldi, PM Clarkson, SM Cole, J Keadle, ... Circulation 127 (1), 96-103, 2013 | 637 | 2013 |
| High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis M Tomaszewski, C White, P Patel, N Masca, R Damani, J Hepworth, ... Heart 100 (11), 855-861, 2014 | 502 | 2014 |
| Understanding heterogeneity in meta‐analysis: the role of meta‐regression WL Baker, C Michael White, JC Cappelleri, J Kluger, CI Coleman, ... International journal of clinical practice 63 (10), 1426-1434, 2009 | 459 | 2009 |
| Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis SA Shah, S Sander, CM White, M Rinaldi, CI Coleman The Lancet infectious diseases 7 (7), 473-480, 2007 | 355 | 2007 |
| Association of inhaled corticosteroids and long-acting β-agonists as controller and quick relief therapy with exacerbations and symptom control in persistent asthma: a … DM Sobieraj, ER Weeda, E Nguyen, CI Coleman, CM White, SC Lazarus, ... Jama 319 (14), 1485-1496, 2018 | 354 | 2018 |
| Biological variation for N-terminal pro-and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure AHB Wu, A Smith, S Wieczorek, JF Mather, B Duncan, CM White, C McGill, ... The American journal of cardiology 92 (5), 628-631, 2003 | 344 | 2003 |
| A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin CM White The Journal of Clinical Pharmacology 42 (9), 963-970, 2002 | 299 | 2002 |
| A review of human studies assessing cannabidiol's (CBD) therapeutic actions and potential CM White The Journal of Clinical Pharmacology 59 (7), 923-934, 2019 | 297 | 2019 |
| Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review AV Hernandez, YM Roman, V Pasupuleti, JJ Barboza, CM White Annals of internal medicine 173 (4), 287-296, 2020 | 296 | 2020 |
| The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes EL Gillespie, CM White, M Kardas, M Lindberg, CI Coleman Diabetes care 28 (9), 2261-2266, 2005 | 292 | 2005 |
| Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis KM Reinhart, CI Coleman, C Teevan, P Vachhani, CM White Annals of Pharmacotherapy 42 (12), 1766-1771, 2008 | 274 | 2008 |
| Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial S Giri, CM White, AB Dunn, K Felton, L Freeman-Bosco, P Reddy, ... The Lancet 357 (9259), 830-836, 2001 | 273 | 2001 |
| Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis WL Baker, R Talati, CM White, CI Coleman Diabetes research and clinical practice 87 (1), 98-107, 2010 | 269 | 2010 |
| Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies B Williams, TM MacDonald, SV Morant, DJ Webb, P Sever, GT McInnes, ... The lancet Diabetes & endocrinology 6 (6), 464-475, 2018 | 247 | 2018 |
| Effect of cinnamon on glucose control and lipid parameters WL Baker, G Gutierrez-Williams, CM White, J Kluger, CI Coleman Diabetes care 31 (1), 41-43, 2008 | 246 | 2008 |
| A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy BA Taylor, L Lorson, CM White, PD Thompson Atherosclerosis 238 (2), 329-335, 2015 | 241 | 2015 |
| The impact of coenzyme Q10 on systolic function in patients with chronic heart failure S Sander, CI Coleman, AA Patel, J Kluger, CM White Journal of cardiac failure 12 (6), 464-472, 2006 | 235 | 2006 |
| The comparative efficacy and safety of the angiotensin receptor blockers in the management of hypertension and other cardiovascular diseases HMA Abraham, CM White, WB White Drug safety 38, 33-54, 2015 | 221 | 2015 |
| Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update JC Song, CM White Clinical pharmacokinetics 41, 207-224, 2002 | 189 | 2002 |
Craig I. ColemanUniversity of ConnecticutVerified email at harthosp.org
